ANNOUNCED AS TEMPORARYNo
Capital injection and equity stakes (including bailouts)
On March 24, 2016, the Innovation Network Corporation of Japan (INCJ) bought 3.5 billion yen (30 million USD) worth of shares in Stella Pharma Co. The investment relates to the boron isotope enrichment technology for boron drugs.
About the Innovation Network Corporation of Japan (INCJ)
In 2009, INCJ was created as a public-private investment fund to financially support industries "next-generation businesses". INCJ supports projects that "combine technologies and varied expertise across industries and materialize open innovation.". According to the INCJ website, the fund has an investment capacity of up to USD 20 billion. Although characterized as a public-private partnership, in fact only 0.1 billion of the 2.6 billion USD invested in the fund was provided by the private sector. The rest came from the Japanese government. Of the 0.1 billion USD said to be contributed by the private sector, 13.6 million USD was in fact provided by the Development Bank of Japan, a state-owned bank.
⚑ Please report this page in case you detect an inaccuracy in its content.